MedPath

MICHAEL GUNN

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM

Phase 1
Withdrawn
Conditions
Glioma, Malignant
Glioblastoma
First Posted Date
2021-02-05
Last Posted Date
2023-05-15
Lead Sponsor
Michael Gunn
Registration Number
NCT04741984

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.